3Lei W, Wen W,Su Z,et al. Comparison of intravenous general an aesthesia vs endotracheal intubation in the surgical management of juvenile onset recurrent respiratory papillomatosis[J].Acta Otolaryn gol,2010,130(2):281-285.
7Naiman AN, Ceruse P, Coulombeau B, et al. Intralesional cidofovir and surgical exdsion for laryngeal papillomatosis[J]. Laryngoscope, 2003, 113(12) :2174-2181.
8Pransky SM, Brewster DF, Magit AE, et al. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis[J]. Arch Otolaryngol Head Neck Surg, 2000,126(10) :1239-1243.
6Tindlle R W. Immunomanipulative strategies for the control of human papillomavirus associatedl cervical disease. Immunol Res, 19997,16: 387- 400.
7Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol, 19999, 99 : 435 - 444.
8Zhang L F,Zhou J,Chen S,et al. HPV6b viruslike particles are potent immunogens without adjuvant in man.Vaccine, 2000,18 : 1051- 1058.
9Peng S W, Frazer I H, Zhou J. Papillomavirus viruslike particles can deliver defined CTL epitopes to the MHC class I pathway. Virology, 1998,240:147-157.
10Brown D R,Bryan J T,Schroeder J M. Neutralization of human papillomavirus type 11 (HPVll) by serum from women vaccinated with yeast-derived HPVllL1 viruslike particles. J Infect Dis, 2001,184 : 1183- 1186.
